Australia shows an alternative to rationing hepatitis C treatment
France to provide universal access to hepatitis C treatment
Low-cost generic hepatitis C drugs match branded products in viral response
$300 hepatitis C combination to enter clinical trials
Indian study proves that more people virally suppressed in a population equals fewer HIV infections
PopART trial shows feasibility of reaching 90-90-90 targets for testing and treatment coverage in Zambia and South Africa